Trials that use: Logistic regression
New to this method? Read the tutorial →
5,900 results
- Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use: Complete Statistical AnalysisIndependent statistical analysis of Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02680145).
- Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients: Complete Statistical AnalysisIndependent statistical analysis of Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PreFaiRIndependent statistical analysis of Comparative Effectiveness of Pregnancy Failure Management Regimens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02012491).
- Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size…
- PrefHERIndependent statistical analysis of Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer: primary endpoint results, effect estimate with confidence…
- Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction: Complete Statistical AnalysisIndependent statistical analysis of Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01337297).
- Pregabalin for the Treatment of Vulvodynia: Complete Statistical AnalysisIndependent statistical analysis of Pregabalin for the Treatment of Vulvodynia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00853229).
- PREHABIndependent statistical analysis of A Supervised Prehabilitation Program for Patients With Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05692323).
- Preliminary Evaluation of CASTLE Barrier Prototype UK: Complete Statistical AnalysisIndependent statistical analysis of Preliminary Evaluation of CASTLE Barrier Prototype UK: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01530087).
- Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback: Complete Statistical AnalysisIndependent statistical analysis of Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Premenstrual Dysphoric Disorder and Antiepileptic Drugs: Complete Statistical AnalysisIndependent statistical analysis of Premenstrual Dysphoric Disorder and Antiepileptic Drugs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00612235).
- PREMIERIndependent statistical analysis of Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01781403).
- Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955394).
- Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft…
- Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preoperative Treatment With Cetuximab and/or IMC-A12: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Treatment With Cetuximab and/or IMC-A12: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00957853).
- PrEP iT!Independent statistical analysis of PrEP iT! Mobile App Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04509076).
- PREPAREIndependent statistical analysis of Pre-operative Alcohol Skin Solutions in Fractured Extremities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03523962).
- PRESERVEIndependent statistical analysis of Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRESERVEIndependent statistical analysis of Prevention of Serious Adverse Events Following Angiography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01467466).
- PRESERVE KneeIndependent statistical analysis of Subchondroplasty® Knee RCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03112200).
- Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04582877).
- PRESSUREwire Study: Complete Statistical AnalysisIndependent statistical analysis of PRESSUREwire Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02935088).
- PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe): Complete Statistical AnalysisIndependent statistical analysis of PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01238835).
- PrevailIIIndependent statistical analysis of Small Financial Incentives to Promote Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02737566).
- Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD: Complete Statistical AnalysisIndependent statistical analysis of Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03676725).
- PREVENTIndependent statistical analysis of Improving Patient Prioritization During Hospital-homecare Transition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04136951).
- PREVENTIndependent statistical analysis of Prazosin to Prevent COVID-19 (PREVENT-COVID Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04365257).
- PREVENTIndependent statistical analysis of Prehabilitation of Veterans With Exercise and Nutrition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04485611).
- PREVENTIndependent statistical analysis of Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02769338).
- PREVENT-HDIndependent statistical analysis of A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019…
- Preventing Propofol-associated Injection Pain: Complete Statistical AnalysisIndependent statistical analysis of Preventing Propofol-associated Injection Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00864682).
- Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03207386).
- Preventing Sickle Cell Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sickle Cell Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02373241).
- Preventing Staphylococcal (Staph) Infection: Complete Statistical AnalysisIndependent statistical analysis of Preventing Staphylococcal (Staph) Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00108160).
- Preventing Violence Among Veterans in Substance Use Disorder Treatment: Complete Statistical AnalysisIndependent statistical analysis of Preventing Violence Among Veterans in Substance Use Disorder Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01337973).
- Prevention of Acute Kidney Injury in Cardiac Surgery Patients: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Acute Kidney Injury in Cardiac Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00921518).
- Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS): Complete Statistical AnalysisIndependent statistical analysis of Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01171794).
- Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Bone Loss After Acute SCI by Zoledronic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02325414).
- Prevention of GBS Colonization Via Immunity: Complete Statistical AnalysisIndependent statistical analysis of Prevention of GBS Colonization Via Immunity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00128219).
- Prevention of Musculoskeletal Injuries in Slovenian Armed Forces: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Musculoskeletal Injuries in Slovenian Armed Forces: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03415464).
- Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00381615).
- Previously Implanted Pudendal Nerve Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Previously Implanted Pudendal Nerve Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04473469).
- Priapism in Boys and Men With Sickle Cell Disease – Demographics, Characteristics and Prevalence: Complete Statistical AnalysisIndependent statistical analysis of Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRIDEIndependent statistical analysis of A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PRIDEIndependent statistical analysis of PRIDE: Preventing Respiratory Illnesses During Childhood Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00927264).
- PRIDE-HTIndependent statistical analysis of PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…